Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

We investigated thrombocytopenic, thromboembolic and hemorrhagic events following a second dose of ChAdOx1 and BNT162b2 using a self-controlled case series analysis. We used a national prospective cohort with 2.0 million(m) adults vaccinated with two doses of ChAdOx or 1.6 m with BNT162b2. The incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Colin R., Kerr, Steven, Katikireddi, Srinivasa Vittal, McCowan, Colin, Ritchie, Lewis D., Pan, Jiafeng, Stock, Sarah J., Rudan, Igor, Tsang, Ruby S. M., de Lusignan, Simon, Hobbs, F. D. Richard, Akbari, Ashley, Lyons, Ronan A., Robertson, Chris, Sheikh, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377297/
https://www.ncbi.nlm.nih.gov/pubmed/35970827
http://dx.doi.org/10.1038/s41467-022-32264-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377297/
https://www.ncbi.nlm.nih.gov/pubmed/35970827
http://dx.doi.org/10.1038/s41467-022-32264-6

Ejemplares similares